PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9788895-5	1998	In this review we consider the relative contribution of oxidative stress to the effects of PTP inhibition by vanadium-based compounds in lymphocytes.	Vanadium	109-117	protein tyrosine phosphatase receptor type U	Homo sapiens	91-94	
26053397-3	2015	We describe the exact mechanism of the effect of vanadium compounds on protein tyrosine phosphatases (PTP), epidermal growth factor receptor (EGFR), PLCgamma, Src, mitogen-activated protein kinase (MAPK) cascades, transcription factor NF-kappaB, the effect on the proteolysis of COX-2 and the activity of cPLA2.	Vanadium	49-57	protein tyrosine phosphatase receptor type U	Homo sapiens	102-105	
35159385-9	2022	Vanadium compounds are well-known PTP inhibitors and AMPK activators.	Vanadium	0-8	protein tyrosine phosphatase receptor type U	Homo sapiens	34-37